News: Press releases
At the Porterhouse Medical Group, we are delighted to announce the launch of our newly branded internship programme, Porterhouse Pathfinders.
The Porterhouse Medical Group comprises medical communications, market research and insights professionals, with offices in the UK and the USA. We work with clients across the globe to generate insight and to develop creative scientific and medical communications with maximum impact.
Each year, Porterhouse Medical chooses a local charity to support as a key part of our mission to improve people’s lives. In 2017, we partnered up with SportsAble, an organisation that supports people with disabilities through sports and social activities (www.sportsable.co.uk). We raised a total of £2,544 through numerous events, such as a team-building day at the centre run by SportsAble in Maidenhead, and the SportsAble Static Wheelchair Push Challenge at our offices in Reading. This year, we are proud to announce that we will be raising funds for another admirable local charity: The Willows Support Group.
Porterhouse Medical Group is delighted to announce the launch of Porterhouse Insights, a global strategic research, insight and evidence consultancy, offering offer nimble and agile solutions to global biopharmaceutical companies. It will be led by Fabrice Allum, an experienced insight professional.
UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is to be headed by two experienced medical communications professionals, with a long track record of leading successful businesses in the US.
The 2017 Women in Business Awards shortlist – released yesterday – includes an impressive three ‘finalist’ nominations for Porterhouse Medical across three award categories. Senior Medical Writers Lisa Gallacher and Gillian Hancey have been nominated for individual awards, with the company also being nominated for an employer award.
Porterhouse Medical, winner of the Queen’s Award for Enterprise, was delighted to welcome Rob Wilson MP to open our new office in Windsor Square this month.
Promising news for patients with Parkinson’s Disease (PD) was reported at the 13th International Conference on Alzheimer’s and Parkinson’s Diseases in Vienna earlier this month. PRX002/RG7935, currently in Phase 1b clinical trials, has been identified as having an acceptable safety profile and is expected to go into phase 2 clinical trials in the next few months.
The team at Porterhouse Medical is proud to have been given the ‘Highly Commended’ award at the Thames Valley Business Magazine’s 2016 Awards Ceremony last week, in the SME (Small and Medium-sized Enterprises) category.
We are delighted to announce that we have received Investors in People (IIP) accreditation at the Silver level. IIP accreditation is an internationally recognised and rigorously assessed performance framework that demonstrates a company’s commitment to staff training and development. Organisations that meet the world-recognised IIP Standard reflect the very best in people management excellence.
We are delighted and proud to announce that Porterhouse Medical has been recognized with the Queen’s Award for Enterprise 2016 – the UK’s highest accolade for outstanding achievement in business.